Axitinib and Avelumab in Treating Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma

NCT03990571 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Adenoid Cystic Carcinoma
Progressive Disease
Recurrent Adenoid Cystic Carcinoma

Interventions

DRUG: Avelumab
DRUG: Axitinib

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]